(Q40885260)

English

Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 September 2017

Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial (English)

1 reference

Europe PubMed Central

24 September 2017

phase III clinical trial

0 references

1 reference

based on heuristic

inferred from title

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Jean-Luc Labourey

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Philippe Beuzeboc

26

object named as

Philippe Beuzeboc

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Nadine Houédé

9

object named as

Nadine Houede

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Laura Faivre

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

François Lesaunier

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Remy Delva

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Gwenaëlle Gravis

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Frédéric Rolland

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Frank Priou

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Jean-Marc Ferrero

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Loïc Mourey

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Christine Theodore

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Ivan Krakowski

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Jean-François Berdah

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Marjorie Baciuchka

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Brigitte Laguerre

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Aude Fléchon

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Isabelle Cojean-Zelek

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Stéphane Oudard

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Paule Chinet-Charrot

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Eric Legouffe

22

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Jean-Léon Lagrange

23

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Claude Linassier

24

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Gaël Deplanque

25

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Jean-Louis Davin

27

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Anne-Laure Martin

28

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Muriel Habibian

29

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Agnès Laplanche

30

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Stéphane Culine

31

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Karim Fizazi

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

publication date

28 May 2015

1 reference

Europe PubMed Central

24 September 2017

Lancet Oncology Commission

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

787-794

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Prostate cancer: ESMO Consensus Conference Guidelines 2012

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900011-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate cancer, version 2.2014

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900011-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900011-X

7 January 2021

based on heuristic

inferred from DOI database lookup

External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900011-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900011-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Ten-year follow-up of radiation therapy oncology group protocol 92-02: a phase III trial of the duration of elective androgen deprivation in locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900011-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900011-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Final Report of the Intergroup Randomized Study of Combined Androgen-Deprivation Therapy Plus Radiotherapy Versus Androgen-Deprivation Therapy Alone in Locally Advanced Prostate Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900011-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Duration of androgen suppression in the treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900011-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900011-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III Trial Comparing Whole-Pelvic Versus Prostate-Only Radiotherapy and Neoadjuvant Versus Adjuvant Combined Androgen Suppression: Radiation Therapy Oncology Group 9413

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900011-X

7 January 2021

based on heuristic

inferred from DOI database lookup

High-risk prostate cancer-classification and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900011-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900011-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900011-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Addition of estramustine to chemotherapy and survival of patients with castration-refractory prostate cancer: a meta-analysis of individual patient data

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900011-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase III trial of docetaxel-estramustine in high-risk localised prostate cancer: a planned analysis of response, toxicity and quality of life in the GETUG 12 trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900011-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The GETUG 70 Gy vs. 80 Gy randomized trial for localized prostate cancer: feasibility and acute toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900011-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900011-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A Multiple Testing Procedure for Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900011-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of adjuvant estramustine phosphate, cyclophosphamide, and observation only for node-positive patients following radical prostatectomy and definitive irradiation. Investigators of the National Prostate Cancer Project

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900011-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant mitozantrone chemotherapy in advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900011-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Achievements and perspectives in prostate cancer phase 3 trials from genitourinary research groups in Europe: introducing the Prostate Cancer Consortium in Europe.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900011-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900011-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900011-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomization reveals unexpected acute leukemias in Southwest Oncology Group prostate cancer trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900011-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for hi

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900011-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(15)00011-X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26028518%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40885260&oldid=1909571713"